Skip to main content

Table 6 Summary of efficacy assessment scores

From: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis

Test Baseline 1 month 1 year
EDSS mean scores 5.2 4.8* 4.5*
SNRS bladder/bowel/sexual dysfunction score (normal = 0) − 4.7 − 2.7* − 3.1
Nine Hole Peg Test—non-dominant hand average scores 35.1 30.2* 34.1
25-foot walk (second trial) times 17.5 11.5* 13.3
RAND SF-36 average scale 53.5 68.3*** 63.5
  1. * p < 0.05 when compared to baseline; *** p < 0.001 when compared to baseline